| The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers (NCT02581696) | Boryung Pharmaceutical Co., Ltd | 2015-08-01 |
| Dacorin for Proliferative Vitreoretinopathy (NCT02865031) | Cairo University | 2015-08-01 |
| Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer (NCT02520115) | Barbara Ann Karmanos Cancer Institute | 2015-08-01 |
| Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment Interruption (NCT02463227) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-08-01 |
| SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women (NCT02499874) | St Stephens Aids Trust | 2015-08-01 |
| Potential Food Effect And Repeated Dosing of AX-024.HCl In Healthy Subjects (NCT02546635) | Artax Biopharma Inc | 2015-08-01 |
| Pilot Clinical Evaluation of Approved Contact Lenses (NCT02540122) | Johnson & Johnson Vision Care, Inc. | 2015-08-01 |
| Pharmacodynamic Study of Cilostazol in Healthy Volunteers (NCT02554721) | Otsuka Pharmaceutical Co., Ltd. | 2015-08-01 |
| NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG (NCT02611245) | Chinese Academy of Sciences | 2015-08-01 |
| A Study of CriPec® Docetaxel Given to Patients With Solid Tumours (NCT02442531) | Cristal Therapeutics | 2015-08-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers (NCT02480296) | MyoKardia, Inc. | 2015-08-01 |
| EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma (NCT02521090) | Barbara Ann Karmanos Cancer Institute | 2015-08-01 |
| The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates (NCT02448446) | South Coast Retina Center; Carson, McBeath, Boswell, Inc. | 2015-08-01 |
| Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali (NCT02535767) | University of California, San Francisco | 2015-08-01 |
| Gabapentin in Patients at Clinical Risk for Psychosis (NCT02557945) | New York State Psychiatric Institute | 2015-08-01 |
| FMT for Multidrug Resistant Organism Reversal (NCT02312986) | Washington University School of Medicine | 2015-08-01 |
| Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer (NCT02571530) | Northwell Health | 2015-08-01 |
| Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability (NCT02603822) | Mayo Clinic | 2015-08-01 |
| Dose Escalation Study of PF-06741086 In Healthy Subjects (NCT02531815) | Pfizer | 2015-08-01 |
| Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia (NCT02518568) | Pierre Fabre Medicament | 2015-08-01 |
| A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers (NCT02627027) | Chong Kun Dang Pharmaceutical | 2015-08-01 |
| Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology (NCT02527941) | University of Toronto | 2015-08-01 |
| Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells (NCT02549625) | Timothy J Nelson, MD, PhD | 2015-08-01 |
| To Assess the Bioequivalence of Two Pacritinib Drug Product Formulations and FMI Formulation Following Oral Administration in Healthy Subjects (NCT02823171) | CTI BioPharma | 2015-08-01 |
| Relative Bioavailability of 2 Oral Formulations of Nintedanib (NCT02572752) | Boehringer Ingelheim | 2015-08-01 |
| A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet (NCT02566187) | Boryung Pharmaceutical Co., Ltd | 2015-08-01 |
| Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers (NCT02992236) | veriNOS operations GmbH | 2015-08-01 |
| Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain (NCT02372591) | Johns Hopkins University | 2015-08-01 |
| Zambia SiVET MMR Tdap-IPV (NCT02589678) | Emory University | 2015-08-01 |
| Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients (NCT02614846) | Jiangsu HengRui Medicine Co., Ltd. | 2015-08-01 |
| Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib (NCT02357732) | University of Pittsburgh | 2015-08-01 |
| CKD-391 Pharmacokinetic Study Phase I (NCT02501200) | Chong Kun Dang Pharmaceutical | 2015-08-01 |
| An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT02522910) | Yonsei University | 2015-08-01 |
| Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer (NCT02539719) | Stemcentrx | 2015-08-01 |
| Ganoderma Tea on Eczema Patient (NCT02533635) | Hong Kong Baptist University | 2015-08-01 |
| Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease (NCT02528799) | ImmusanT, Inc. | 2015-08-01 |
| Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction (NCT02496845) | VasoLead (2012) Ltd. | 2015-08-01 |
| Safety, Tolerability and Host Response to Lactobacillus Johnsonii (NCT02349360) | University of Florida | 2015-08-01 |
| A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL (NCT02557633) | Allergy Therapeutics | 2015-08-01 |
| CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) (NCT02580448) | Innocrin Pharmaceutical | 2015-08-01 |
| Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers (NCT02700360) | Enzychem Lifesciences Corporation | 2015-08-01 |
| Aralast NP in Islet Transplant (NCT02520076) | University of Alberta | 2015-08-01 |
| Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective (NCT02504476) | Amgen | 2015-08-01 |
| Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma (NCT02519114) | Maastricht University Medical Center | 2015-08-01 |
| A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers (NCT02529293) | Adocia | 2015-08-01 |
| Wheelchair Indoors Curling With SCI patients_RCT (NCT02550834) | HES-SO Valais-Wallis | 2015-08-01 |
| Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training (NCT02926352) | University of Texas at Austin | 2015-08-01 |
| Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT02277197) | James J Lee | 2015-08-01 |
| Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors (NCT02498912) | Memorial Sloan Kettering Cancer Center | 2015-08-01 |
| Cranberry Extract and Urinary Infection Prevention: a Clinical Trial (NCT02572895) | Laval University | 2015-08-01 |
| Pharmacokinetic Study in Healthy Volunteers (NCT02554734) | Orion Corporation, Orion Pharma | 2015-08-01 |
| A Study of a New LY900014 Formulation in Healthy Participants (NCT02525744) | Eli Lilly and Company | 2015-08-01 |
| Topical Use of Difinsa53™ to Prevent Radiation Dermatitis (NCT02534129) | ProTechSure Scientific, Inc. | 2015-08-01 |
| An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients (NCT02555709) | Vitae Pharmaceuticals Inc., an Allergan affiliate | 2015-08-01 |
| A Controlled Study to Evaluate the Safety and Immunogenicity of StreptAnova™ in Healthy Adults (NCT02564237) | Dalhousie University | 2015-08-01 |
| Liver Cancer HepaSphere Combined With Cryosurgery (NCT02545556) | Fuda Cancer Hospital, Guangzhou | 2015-08-01 |
| A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers (NCT02467361) | Sumitomo Pharma America, Inc. | 2015-08-01 |
| A Multiple Ascending-Dose Study of RG7625 in Healthy Volunteers (NCT02521610) | Hoffmann-La Roche | 2015-08-01 |
| Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF) (NCT02801890) | Royan Institute | 2015-08-01 |
| Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults (NCT02431767) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-08-01 |
| Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy Adults (NCT02476864) | Actelion | 2015-08-01 |
| The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease (NCT02917122) | National Cheng-Kung University Hospital | 2015-08-01 |
| The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. (NCT02494349) | Jeil Pharmaceutical Co., Ltd. | 2015-08-01 |
| Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer (NCT02555397) | Henry Ford Health System | 2015-08-01 |
| Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine (NCT02419391) | Bavarian Nordic | 2015-08-01 |
| Complementary Combination Therapy for Cocaine Dependence (NCT02538744) | Baylor College of Medicine | 2015-08-01 |
| BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone (NCT02670018) | LG Life Sciences | 2015-08-01 |
| Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS) (NCT02762136) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2015-08-01 |
| A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants (NCT02629289) | Pfizer | 2015-08-01 |
| Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects (NCT02461914) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2015-08-01 |
| Basmisanil Positron Emission Tomography Study in Japanese Volunteers (NCT02534207) | Hoffmann-La Roche | 2015-08-01 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime (NCT02532140) | Wockhardt | 2015-08-01 |
| Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions (NCT02442063) | Bayer | 2015-08-01 |
| Hyperthermy Endocavitary Treatment in Pelvic Pain (NCT02837588) | Universidad Rey Juan Carlos | 2015-08-01 |
| A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects (NCT02536209) | Tanabe Pharma Corporation | 2015-08-01 |
| Quantitating the Impact of Plerixafor (NCT02522572) | E. Steve Woodle | 2015-08-01 |
| An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3) (NCT02529930) | Nykode Therapeutics ASA | 2015-08-01 |
| Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults (NCT02564575) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-08-01 |
| Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults (NCT02421367) | U.S. Army Medical Research and Development Command | 2015-08-01 |
| A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC (NCT02321293) | Lady Davis Institute | 2015-08-01 |
| Phase 1, Febuxostat XR Relative Bioavailability Study (NCT02504320) | Takeda | 2015-08-01 |
| (NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors (NCT02508532) | Blueprint Medicines Corporation | 2015-08-01 |
| Facial Function Reanimation by Electrical Pacing in Unilateral Facial Paralysis. (NCT03496025) | Tampere University Hospital | 2015-08-01 |
| Nicotinic Receptors and Schizophrenia (NCT02538081) | VA Office of Research and Development | 2015-08-01 |
| A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer (NCT02453464) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2015-08-01 |
| Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer (NCT02548169) | Baylor Research Institute | 2015-08-01 |
| A Phase I, Open-label Study of Absorption, Metabolism, and Excretion of Defactinib (VS-6063) in Healthy Male Subjects (NCT02913716) | Verastem, Inc. | 2015-08-01 |
| Fiber and Water Improve Bowel Habit in Humans (NCT02838849) | Universidade de Passo Fundo | 2015-08-01 |
| A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants (NCT02525484) | Hoffmann-La Roche | 2015-08-01 |
| A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects (NCT02539550) | Pfizer | 2015-08-01 |
| Study of Endostar Subcutaneous Injection in NSCLC (NCT02652234) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2015-08-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants (NCT02515955) | Janssen-Cilag International NV | 2015-08-01 |
| A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers (NCT02512562) | Alios Biopharma Inc. | 2015-07-31 |
| Rehabilitation Training After Stroke (NCT02429180) | University of Exeter | 2015-07-31 |
| First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C (NCT02510248) | Alios Biopharma Inc. | 2015-07-31 |
| Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis) (NCT02481180) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2015-07-31 |
| A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma (NCT02508467) | Blueprint Medicines Corporation | 2015-07-31 |
| Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma (NCT02468557) | Gilead Sciences | 2015-07-30 |
| Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects (NCT02509104) | GlaxoSmithKline | 2015-07-30 |
| Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers (NCT02487095) | National Cancer Institute (NCI) | 2015-07-30 |